{"id":"W2799641062","doi":"10.1002/ajh.25134","title":"Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Museums Association","keywords":"Placebo; Lenalidomide; Medicine; Clinical endpoint; Internal medicine; Multiple myeloma; Ixazomib; Quality of life (healthcare); Hazard ratio; Dexamethasone; Surgery; Gastroenterology; Randomized controlled trial; Confidence interval; Carfilzomib; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003171321,0.0004843103,0.003589062,0.000619797,0.0001450891,0.00001286126,0.0004614565,0.0001781087,0.0003463119],"category_scores_gemma":[0.009469239,0.0003376593,0.0004344951,0.001125279,0.001545008,0.0001568163,0.0001811089,0.001085534,0.00001158068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002846246,"about_ca_system_score_gemma":0.001200631,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01650953,"about_ca_topic_score_gemma":0.001588156,"domain_scores_codex":[0.9890684,0.003515972,0.004752568,0.0005696352,0.001283609,0.0008098366],"domain_scores_gemma":[0.9832326,0.007407453,0.006482141,0.00105825,0.001110833,0.0007087767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.279097,0.01684036,0.6262485,0.0001285965,0.007242234,0.00149182,0.01716089,0.00005271439,0.006364469,0.00003735459,0.0009892656,0.04434677],"study_design_scores_gemma":[0.4303007,0.08398566,0.3972766,0.001014295,0.000962948,0.001159046,0.07224859,0.0009554719,0.01096379,0.0001320047,0.0002614359,0.0007394841],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942932,0.002173296,0.000126734,0.001293189,0.0004612982,0.001491802,0.00006395121,0.00002356205,0.00007294554],"genre_scores_gemma":[0.9973853,0.0001599337,0.001929092,0.0002447591,0.0001408188,0.00003521942,0.00003171755,0.00005957457,0.00001354253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2289719,"threshold_uncertainty_score":0.9999076,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06886877488201884,"score_gpt":0.3831735620730968,"score_spread":0.3143047871910779,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}